Midterm results of the LEADR trial confirm ongoing safety, efficacy, and reliability of the novel, small-diameter OmniaSecure defibrillation lead
Event: EHRA 2025
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias
